Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok, Philip Chong-Hei; Leung, Kwong Chuen; Cheung, Moon Tong; Lam, Ting Wa; Szeto, Lok Tin; Chou, Sandas Qi-Hua; Chia, Nam Hung; Tong, Cheuk Man; Yuen, Pui Kei; Cheung, Chun Hung; Law, Chun Key.
J Gastroenterol Hepatol
; 29(11): 1897-904, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24734957
External beam radiotherapy for unresectable hepatocellular carcinoma.
A systematic review of publications on charged particle therapy for hepatocellular carcinoma.
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
Current role of selective internal radiation with yttrium-90 in liver tumors.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database.
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Radioembolization for Hepatocellular Carcinoma: A Nationwide 10-Year Experience.
Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival.